Susquehanna International Group’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-2,411,100
| Closed | -$205M | – | 11378 |
|
|
2019
Q4 | $205M | Sell |
2,411,100
-161,500
| -6% | -$10.8M | 0.06% | 261 |
|
|
2019
Q3 | $129M | Buy |
2,572,600
+584,700
| +29% | +$23.3M | 0.04% | 362 |
|
|
2019
Q2 | $72.5M | Buy |
1,987,900
+405,600
| +26% | +$13.2M | 0.03% | 522 |
|
|
2019
Q1 | $44.2M | Buy |
1,582,300
+1,062,500
| +204% | +$25M | 0.02% | 695 |
|
|
2018
Q4 | $9.95M | Buy |
519,800
+60,700
| +13% | +$1.41M | ﹤0.01% | 1608 |
|
|
2018
Q3 | $13.7M | Buy |
459,100
+74,400
| +19% | +$2.8M | ﹤0.01% | 1642 |
|
|
2018
Q2 | $14.1M | Buy |
384,700
+86,800
| +29% | +$2.82M | ﹤0.01% | 1610 |
|
|
2018
Q1 | $9.81M | Buy |
297,900
+71,300
| +31% | +$2.23M | ﹤0.01% | 1796 |
|
|
2017
Q4 | $6.2M | Buy |
226,600
+91,800
| +68% | +$2.83M | ﹤0.01% | 2305 |
|
|
2017
Q3 | $4.99M | Sell |
134,800
-66,900
| -33% | -$2.47M | ﹤0.01% | 2500 |
|
|
2017
Q2 | $7.67M | Sell |
201,700
-176,900
| -47% | -$7.88M | ﹤0.01% | 1928 |
|
|
2017
Q1 | $18.5M | Buy |
378,600
+73,400
| +24% | +$3.35M | 0.01% | 1133 |
|
|
2016
Q4 | $10.4M | Sell |
305,200
-412,200
| -57% | -$14.6M | 0.01% | 1527 |
|
|
2016
Q3 | $27.1M | Buy |
717,400
+518,400
| +261% | +$19.5M | 0.01% | 822 |
|
|
2016
Q2 | $6.69M | Sell |
199,000
-14,700
| -7% | -$518K | ﹤0.01% | 1852 |
|
|
2016
Q1 | $6.79M | Sell |
213,700
-3,800
| -2% | -$124K | ﹤0.01% | 1929 |
|
|
2015
Q4 | $8.12M | Sell |
217,500
-12,500
| -5% | -$472K | ﹤0.01% | 1969 |
|
|
2015
Q3 | $8.73M | Buy |
230,000
+40,100
| +21% | +$1.41M | ﹤0.01% | 1986 |
|
|
2015
Q2 | $5.43M | Buy |
189,900
+25,400
| +15% | +$708K | ﹤0.01% | 2785 |
|
|
2015
Q1 | $4.61M | Buy |
164,500
+104,100
| +172% | +$2.92M | ﹤0.01% | 2859 |
|
|
2014
Q4 | $1.67M | Buy |
60,400
+26,200
| +77% | +$649K | ﹤0.01% | 4800 |
|
|
2014
Q3 | $763K | Sell |
34,200
-82,000
| -71% | -$2.08M | ﹤0.01% | 6452 |
|
|
2014
Q2 | $3.38M | Sell |
116,200
-77,500
| -40% | -$2.07M | ﹤0.01% | 3706 |
|
|
2014
Q1 | $5.5M | Buy |
193,700
+149,600
| +339% | +$4.95M | ﹤0.01% | 2753 |
|
|
2013
Q4 | $1.7M | Buy |
44,100
+9,500
| +27% | +$340K | ﹤0.01% | 4563 |
|
|
2013
Q3 | $1.16M | Sell |
34,600
-118,600
| -77% | -$3.78M | ﹤0.01% | 5029 |
|
|
2013
Q2 | $4.71M | Buy |
+153,200
| New | +$5.13M | ﹤0.01% | 2698 |
|
Other funds holding MDCO
Susquehanna International Group's MDCO Position: Q1 2020 in Review
Susquehanna International Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,082,774 shares — an estimated $92M sold.
Susquehanna International Group first reported a position in MDCO in Q2 2013 and held it in 19 quarters. The position peaked at $92M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Susquehanna International Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Susquehanna International Group sold 1,082,774 Medicines Co shares in Q1 2020, an estimated $92M.
- Susquehanna International Group first reported a position in Medicines Co in Q2 2013 and held it in 19 quarters.
- Susquehanna International Group's Medicines Co position peaked at $92M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.